TBIO
Undervalued by 1983.7% based on the discounted cash flow analysis.
Market cap | $9.96 Million |
---|---|
Enterprise Value | $25.19 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.6 |
Beta | 1.35 |
Outstanding Shares | 30,103,284 |
Avg 30 Day Volume | 55,089 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.21 |
---|---|
PEG | -0.19 |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 0.92 |
Enterprise Value to EBIT | -0.72 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 1.37 |
Debt to Equity | 144.45 |
No data
No data